Researchers have created a test based on tumor organoids - or 3D tissue cultures - that can help predict how patients with advanced colorectal cancer (CRC) may respond to chemotherapy treatment.
In a prospective clinical trial, their organoid-based test predicted responses in 80% of patients treated with the standard therapy irinotecan. Their system may help identify patients who may not respond to toxic chemotherapies and could ultimately assist clinicians in designing more personalized and efficient chemotherapy treatments.
Chemotherapy is considered the backbone of most cancer therapies, but many patients do not respond to treatment and experience severe side effects. Scientists have therefore made it a priority to develop methods that can predict which patients are most likely to benefit from chemotherapy drugs. However, many of these approaches have had only limited success or are still early in development.
Researchers created a new strategy that uses organoid models of a patient's own tumor to predict how their cancer might respond to chemotherapy drugs.
They gathered samples from 61 patients with metastatic CRC and used the tissue to generate organoids, which they treated with irinotecan either alone or in combination with the chemotherapy 5-FU. The organoid system generally reflected how the patients responded to the treatments, correctly classifying 80% of patients treated with irinotecan.
Furthermore, the organoids could be generated and screened within 21 days - a substantial improvement over previous systems that required two to six months of preparation. The researchers note the organoids could not predict how patients responded to a combination of 5-FU and the drug oxaliplatin.
Nevertheless, the findings suggest that with further improvement, patient-derived organoids could help prevent cancer patients from receiving unnecessary irinotecan-based treatments.
https://stm.sciencemag.org/content/11/513/eaay2574
Predicting chemotherapy response using patient-derived organoids
- 1,377 views
- Added
Edited
Latest News
The assembly of the human c…
By newseditor
Posted 24 Apr
Wiring of the human neocortex
By newseditor
Posted 24 Apr
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
Other Top Stories
New HIV vaccine target!
Read more
Twin study finds that gut microbiomes run in families
Read more
Genetically engineered world's first Zika virus infectious cDNA clone!
Read more
How antibodies access neurons to fight infection
Read more
Why humans (and not mice) are susceptible to Zika
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Integrative spatial analysi…
By newseditor
Posted 24 Apr
Time-series reconstruction…
By newseditor
Posted 24 Apr
Harnessing gastrointestinal…
By newseditor
Posted 24 Apr
Sex-specific modulation of…
By newseditor
Posted 24 Apr
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar